Rivastigmine tartrate
USP/1604858 - United States Pharmacopeia (USP) Reference Standard
Synonym: ENA-713; Ethylmethyl-carbamic acid 3-
CAS Number: 129101-54-8
Empirical Formula (Hill Notation): C14H22N2O2 · C4H6O6
Molecular Weight: 400.42
Linear Formula: C14H22N2O2 · C4H6O6
Product Type: Chemical
API family | rivastigmine |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C14H22N2O2.C4H6O6/c1-6 |
InChI key | GWHQHAUAXRMMOT-RWALOXMOSA |
manufacturer/tradename | USP |
storage temp. | 2-8°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Rivastigmine Tartrate USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. Also, for use with USP monograph such as Rivastigmine Tartrate Capsules. |
Biochem/physiol Actions: | Rivastigmine is an orally available, brain penetrant, reversible cholinesterase inhibitor that enhances cognitive function in patients with Alzheimer′s and Parkinson′s diseases. Rivastigmine inhibits both butyrylcholinesterase and acetylcholinesterase. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Symbol | GHS06,GHS09 |
Signal word | Danger |
Hazard statements | H300 - H411 |
Precautionary statements | P264 - P270 - P273 - P301 + P310 - P391 - P405 |
RIDADR | UN 2811 6.1 / PGII |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |